Belite Bio Inc ADR (BLTE) — Strategic Asset Allocation Index
Belite Bio Inc ADR (BLTE) has a Strategic Asset Allocation Index of 36.4% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $280.17 Million) total $280.17 Million, measured against net assets of $770.49 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Belite Bio Inc ADR balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Belite Bio Inc ADR Strategic Asset Allocation Index (2024–2025)
This chart shows how Belite Bio Inc ADR's Strategic Asset Allocation Index has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the index stands at 36.4%, representing strategic assets of $280.17 Million against net assets of $770.49 Million USD. For live market cap and overall valuation, see BLTE stock market capitalisation.
Annual Strategic Asset Allocation Index for Belite Bio Inc ADR (2024–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Belite Bio Inc ADR from 2024 to 2025, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Belite Bio Inc ADR (BLTE) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 36.4% | $280.17 Million | $- | $280.17 Million | $770.49 Million | ▲ +36.4 pp |
| 2024 | 0.0% | $0.00 | $- | $0.00 | $145.82 Million | — |